Breathe Well Live Well
Yahoo News |
Mylan sets sights on production of generic asthma inhaler
Tribune-Review Besides providing a cheaper alternative for asthma sufferers across the country, being first to market with generic Advair is seen as key to Mylan's drive to boost growth and hit an ambitious earnings target of adjusted net income of at least $6 a … Mylan: Advair Generic Ready For Launch |
View full post on asthma – Google News
|
Mylan Launches First Bioequivalent Alternative to Combination Asthma Therapy …
MarketWatch Mylan President Rajiv Malik said, "Mylan is excited to be the first company to offer adult asthma patients in the UK the generic version of Seretide Evohaler, delivering on our mission to increase access to high quality medicine. Sirdupla represents a … |
View full post on asthma – Google News
Philly.com (blog) |
Mylan shares jump after FDA lays out guidelines for asthma generic
MarketWatch (blog) Shares of Mylan Inc. jumped nearly 5% in mid-afternoon trades on Tuesday after it became clear the U.S. Food and Drug Administration's guidelines on generic forms of GlaxoSmithKline's asthma medication Advair would work in favor of Mylan, considered a … FDA issues generic guidance on GSK's top-selling asthma drug, Advair GlaxoSmithKline Shares Fall After Advair Setback GSK shares hit as Advair generic threat grows in US |
View full post on asthma – Google News
|
Teva Asthma Drug Would Infringe Mylan Patent, Judge Says
Law360 (subscription) Law360, New York (July 17, 2013, 7:18 PM ET) — A West Virginia federal judge ruled Wednesday that an asthma treatment proposed by generic drugmaker Teva Pharmaceutical USA Inc. would violate a patent covering Mylan Inc.'s Perforomist treatment. |
View full post on asthma – Google News
|
Mylan settles suit over asthma, allergy drug
Drug Store News PITTSBURGH — Mylan has settled a patent infringement suit over a drug used to treat respiratory diseases, Mylan said. The generic drug maker said it resolved a patent litigation suit filed by Shionogi and Cima Labs over prednisolone sodium phosphate … |
View full post on asthma – Google News
|
Mylan to challenge court decision over generic asthma, COPD drug
Drug Store News … in the US District Court for the District of Delaware when the latter sought to market a generic version of Sunovion's Xopenex (levalbuterol hydrochloride) inhalation solution, a drug for asthma and chronic obstructive pulmonary disease. Mylan to fight $18M patent infringement ruling |
View full post on asthma – Google News
|
Mylan faces lawsuit over asthma drug application
Bloomberg … filed with the Food and Drug Administration to make a generic version of Orapred, a steroid used to reduce inflammation in asthma and other conditions. … |
View full post on asthma – Google News